Search for the latest updates on diabetes
News
Boston Therapeutics Reports Topline U.S.-Based Phase IIb Study Results of BTI-320 in Patients With Type 2 Diabetes Marketwired via Yahoo! Finance - 33 minutes
MANCHESTER, NH--(Marketwired - Oct 9, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment